JOHN CZAJKOWSKI, NCI deputy director for management, has accepted a position as executive dean of administration at Harvard Medical School. His start date will be June 2.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
